Science In Price To Sales vs. Cash Flow From Operations

SIS Stock   27.00  0.50  1.89%   
Considering Science In's profitability and operating efficiency indicators, Science in Sport may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Science In's ability to earn profits and add value for shareholders.
For Science In profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Science In to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Science in Sport utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Science In's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Science in Sport over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Please note, there is a significant difference between Science In's value and its price as these two are different measures arrived at by different means. Investors typically determine if Science In is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science In's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Science in Sport Cash Flow From Operations vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Science In's current stock value. Our valuation model uses many indicators to compare Science In value to that of its competitors to determine the firm's financial worth.
Science in Sport is currently regarded as top stock in price to sales category among its peers. It also is currently regarded as top stock in cash flow from operations category among its peers making about  2,819,089  of Cash Flow From Operations per Price To Sales. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Science In's earnings, one of the primary drivers of an investment's value.

Science Cash Flow From Operations vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Science In

P/S

 = 

MV Per Share

Revenue Per Share

 = 
1.15 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Science In

Operating Cash Flow

 = 

EBITDA

-

Taxes

 = 
3.25 M
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.

Science Cash Flow From Operations Comparison

Science In is currently under evaluation in cash flow from operations category among its peers.

Science In Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Science In, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Science In will eventually generate negative long term returns. The profitability progress is the general direction of Science In's change in net profit over the period of time. It can combine multiple indicators of Science In, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-84 K-88.2 K
Operating Income-9.7 M-9.2 M
Income Before Tax-11.3 M-10.7 M
Total Other Income Expense Net-1.6 M-1.5 M
Net Loss-11.3 M-10.7 M
Income Tax Expense-12 K-11.4 K
Net Loss-11.3 M-10.7 M
Net Loss-9.8 M-9.3 M
Net Interest Income-1.6 M-1.5 M
Change To Netincome1.6 M1.5 M

Science Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Science In. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Science In position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Science In's important profitability drivers and their relationship over time.

Use Science In in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Science In position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Science In will appreciate offsetting losses from the drop in the long position's value.

Science In Pair Trading

Science in Sport Pair Trading Analysis

The ability to find closely correlated positions to Science In could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Science In when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Science In - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Science in Sport to buy it.
The correlation of Science In is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Science In moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Science in Sport moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Science In can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Science In position

In addition to having Science In in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Power Assets Thematic Idea Now

Power Assets
Power Assets Theme
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Science Stock

To fully project Science In's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Science in Sport at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Science In's income statement, its balance sheet, and the statement of cash flows.
Potential Science In investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Science In investors may work on each financial statement separately, they are all related. The changes in Science In's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Science In's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.